KFGK
TEVA icon

Keystone Financial Group (Kentucky)’s Teva Pharmaceuticals TEVA Stock Holding History

Keystone Financial Group (Kentucky)’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$931K Sell
27,491
-3,000
-10% -$99.9K 0.06% 230
2026
Q1 		$918K Sell
30,491
-3,853
-11% -$124K 0.06% 208
2025
Q4 		$1.07M Sell
34,344
-4,460
-11% -$110K 0.08% 167
2025
Q3 		$784K Sell
38,804
-600
-2% -$10.5K 0.06% 187
2025
Q2 		$660K Sell
39,404
-12
-0% -$194 0.06% 199
2025
Q1 		$606K Sell
39,416
-738
-2% -$13.2K 0.06% 193
2024
Q4 		$885K Sell
40,154
-1,450
-3% -$26.4K 0.09% 153
2024
Q3 		$750K Sell
41,604
-1,400
-3% -$24.5K 0.1% 146
2024
Q2 		$699K Sell
43,004
-2,400
-5% -$37K 0.25% 62
2024
Q1 		$641K Sell
45,404
-950
-2% -$12K 0.09% 146
2023
Q4 		$484K Sell
46,354
-900
-2% -$8.4K 0.08% 153
2023
Q3 		$482K Sell
47,254
-1,300
-3% -$12.1K 0.08% 160
2023
Q2 		$366K Buy
+48,554
New +$394K 0.06% 193
2022
Q4 		$446K Sell
48,954
-300
-0.6% -$2.62K 0.09% 159
2022
Q3 		$397K Buy
49,254
+2,908
+6% +$25.7K 0.08% 167
2022
Q2 		$349K Sell
46,346
-2,500
-5% -$21.8K 0.07% 187
2022
Q1 		$459K Buy
48,846
+1,250
+3% +$10.4K 0.08% 167
2021
Q4 		$381K Sell
47,596
-200
-0.4% -$1.8K 0.06% 200
2021
Q3 		$466K Buy
47,796
+3,200
+7% +$30K 0.08% 168
2021
Q2 		$442K Buy
44,596
+4,400
+11% +$46.6K 0.08% 170
2021
Q1 		$464K Hold
40,196
– – 0.09% 162
2020
Q4 		$388K Sell
40,196
-2,700
-6% -$25.9K 0.08% 162
2020
Q3 		$386K Buy
42,896
+1,415
+3% +$15K 0.09% 153
2020
Q2 		$511K Buy
41,481
+435
+1% +$4.92K 0.14% 127
2020
Q1 		$369K Buy
41,046
+2,700
+7% +$27.7K 0.12% 133
2019
Q4 		$376K Sell
38,346
-900
-2% -$8.04K 0.1% 152
2019
Q3 		$270K Buy
39,246
+8,650
+28% +$66.3K 0.08% 185
2019
Q2 		$282K Buy
30,596
+3,525
+13% +$42.5K 0.09% 172
2019
Q1 		$424K Sell
27,071
-185
-0.7% -$3.26K 0.15% 128
2018
Q4 		$420K Sell
27,256
-515
-2% -$10.6K 0.19% 111
2018
Q3 		$596K Hold
27,771
– – 0.24% 106
2018
Q2 		$680K Buy
27,771
+4
+0% +$82 0.38% 69
2018
Q1 		$466K Buy
27,767
+1,250
+5% +$24.4K 0.26% 90
2017
Q4 		$507K Buy
+26,517
New +$399K 0.32% 65

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Keystone Financial Group (Kentucky)'s TEVA Position: Q2 2026 in Review

Keystone Financial Group (Kentucky) reduced its Teva Pharmaceuticals (TEVA) stake by 9.8% in Q2 2026, selling an estimated $99.9K and leaving 27,491 shares worth $931K. The position accounts for 0.06% of the portfolio, ranked #230.

Keystone Financial Group (Kentucky) first reported a position in TEVA in Q4 2017 and has held it in 34 quarters since. The position peaked at $1.07M in Q4 2025. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Keystone Financial Group (Kentucky) held 27,491 shares of Teva Pharmaceuticals worth $931K as of Q2 2026.
  • Keystone Financial Group (Kentucky) sold 3,000 Teva Pharmaceuticals shares in Q2 2026, an estimated $99.9K.
  • Teva Pharmaceuticals made up 0.06% of Keystone Financial Group (Kentucky)'s portfolio in Q2 2026, its #230 holding.
  • Keystone Financial Group (Kentucky) first reported a position in Teva Pharmaceuticals in Q4 2017 and has held it in 34 quarters since.
  • Keystone Financial Group (Kentucky)'s Teva Pharmaceuticals position peaked at $1.07M in Q4 2025.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Keystone Financial Group (Kentucky)'s 13F filing for Q2 2026, filed 29 Jul 2026.